神州细胞 (688520)
Sinocelltech Group Limited
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 44533.57
- Circulating A-Shares(W): 44533.57
- Earnings Per Share(RMB): -0.6000
- Net Assets Per Share(RMB): -1.6260
- Operating Revenue(W RMB): 131188.11
- Total Profit(W RMB): -25127.96
- **Net Profit Attributable to Parent(W RMB) **: -25067.23
- Net Profit Growth Rate(%): -267.17
- Weighted Return on Equity(%): -1491.8700
- Operating Cash Flow Per Share(RMB): -0.6890
- Undistributed Profit Per Share(RMB): -9.1730
- Capital Reserve Per Share(RMB): 6.5479
2. Main Business
The main business covers:
- Research, development and industrialization of biopharmaceutical products including monoclonal antibodies, recombinant proteins and vaccines
- Research, development and industrialization of biopharmaceutical products for multiple therapeutic and preventive areas including malignant tumors, autoimmune diseases, infectious diseases and genetic diseases
3. Company Basic Information
- Company Name: Beijing Sinocelltech Ltd.
- Listing Date: 2020-06-22
- Industry: Pharmaceutical Manufacturing
- Address: Room 307, Building 5, No. 31 Yard, Ke Chuang 7th Street, Beijing Economic-Technological Development Area, Beijing
- Website: https://www.sinocelltech.com
- Company Profile: Beijing Sinocelltech Ltd. is a company focusing on the research, development and industrialization of biopharmaceutical products, mainly involving monoclonal antibodies, recombinant proteins and vaccines, covering multiple therapeutic and preventive areas including malignant tumors, autoimmune diseases, infectious diseases and genetic diseases.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Lhasa Ailik Investment Consulting Co., Ltd. | General Legal Person | 27121.28 | 60.90 |
| 2 | Nanchang Sinocell Anyuan Enterprise Management Consulting Partnership (Limited Partnership) | General Legal Person | 2039.48 | 4.58 |
| 3 | Lhasa Lianghaoyuan Investment Consulting Co., Ltd. | General Legal Person | 2000.60 | 4.49 |
| 4 | Nanchang Sinocell Anheng Enterprise Management Consulting Partnership (Limited Partnership) | General Legal Person | 715.72 | 1.61 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 461.68 | 1.04 |
| 6 | CSI 500 Exchange Traded Fund | Fund | 260.91 | 0.59 |
| 7 | Anyi Sinocell Ancheng Enterprise Management Consulting Partnership (Limited Partnership) | General Legal Person | 180.25 | 0.40 |
| 8 | Anyi Sinocell Anqian Enterprise Management Consulting Partnership (Limited Partnership) | General Legal Person | 179.97 | 0.40 |
| 9 | Yinhua CSI Innovative Pharmaceutical Industry Exchange Traded Fund | Fund | 178.93 | 0.40 |
| 10 | Qianhai Open Source Refinancing Theme Selected Stock Securities Investment Fund | Fund | 34.68 | 0.08 |
5. Concept Sectors
- Biological Vaccines
- Gene Concept
- Baidu Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Private Placement Plan
- Risk Warning
- Low Safety Score
- Small Cap Growth
- SZSE Growth
- STAR Market Biotech
- SZSE Emerging Index
- STAR Market 100
Remarks
- Data update date: 2025-11-07
- Data source: Public Market Information